PROCEPT BIOROBOTICS CORPORATION - COMMON STOCK

PROCEPT BioRobotics Corporation Announces Pricing of Offering of Common Stock

29 Oct 2024 19:43:29 By Nasdaq GlobeNewswire

PROCEPT BioRobotics Corporation Announces Proposed Offering of Common Stock

28 Oct 2024 15:19:20 By Nasdaq GlobeNewswire

PROCEPT BioRobotics® Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance

28 Oct 2024 06:00:00 By Nasdaq GlobeNewswire

PROCEPT BioRobotics to Report Third Quarter 2024 Financial Results on October 28, 2024

09 Oct 2024 15:04:00 By Nasdaq GlobeNewswire

PROCEPT BioRobotics Received U.S. FDA Approval to Initiate Pivotal Randomized Clinical Study for Prostate Cancer

07 Oct 2024 15:04:00 By Nasdaq GlobeNewswire

PROCEPT BioRobotics to Present at Upcoming 2024 Wells Fargo Healthcare Conference on September 4, 2024

28 Aug 2024 15:03:00 By Nasdaq GlobeNewswire

PROCEPT BioRobotics Announces FDA Clearance of the HYDROS™ Robotic System, the Next-Generation, AI-Powered Platform for Aquablation® Therapy

21 Aug 2024 06:00:00 By Nasdaq GlobeNewswire

PROCEPT BioRobotics® Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue and EBITDA Guidance

01 Aug 2024 15:03:00 By Nasdaq GlobeNewswire

PROCEPT BioRobotics to Report Second Quarter 2024 Financial Results on August 1, 2024

15 Jul 2024 15:03:00 By Nasdaq GlobeNewswire

PROCEPT BioRobotics Announces New CPT® Category I Code from the American Medical Association for Aquablation therapy

17 Jun 2024 15:03:00 By Nasdaq GlobeNewswire

PROCEPT BioRobotics to Present at Upcoming 2024 Truist Securities MedTech Conference on June 18, 2024

03 Jun 2024 15:03:00 By Nasdaq GlobeNewswire

PROCEPT BioRobotics to Present at Upcoming 2024 Leerink Partners Healthcare Crossroads Conference and 44th Annual William Blair Growth Stock Conference

13 May 2024 15:05:00 By Nasdaq GlobeNewswire

Real-World, Long-Term Data Demonstrate Sustained Benefits of Aquablation Therapy for Men with Benign Prostatic Hyperplasia

06 May 2024 07:00:00 By Nasdaq GlobeNewswire

PROCEPT BioRobotics Reports First Quarter 2024 Financial Results and Increases 2024 Revenue Guidance

01 May 2024 06:00:00 By Nasdaq GlobeNewswire

Late Breaking Abstract Presented at the Japanese Urological Association Annual Meeting on Aquablation Therapy Outcomes for Men in Japan with Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia

29 Apr 2024 07:00:00 By Nasdaq GlobeNewswire

PROCEPT BioRobotics Announces 12 Scientific Research Presentations on Aquablation Therapy for the Treatment of Benign Prostatic Hyperplasia at the 2024 AUA Annual Meeting

23 Apr 2024 07:00:00 By Nasdaq GlobeNewswire

PROCEPT BioRobotics Corp. Announces Investor Event at 2024 AUA Annual Meeting in San Antonio, Texas

04 Apr 2024 15:04:00 By Nasdaq GlobeNewswire

PROCEPT BioRobotics to Report First Quarter 2024 Financial Results on May 1, 2024 and Attend the 2024 Bank of America Healthcare Conference on May 15, 2024

02 Apr 2024 15:03:00 By Nasdaq GlobeNewswire

PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2023 Results

27 Feb 2024 15:02:00 By Nasdaq GlobeNewswire

PROCEPT BioRobotics to Present at the 44th Annual TD Cowen Health Care Conference in Boston

12 Feb 2024 15:05:00 By Nasdaq GlobeNewswire